The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
143
Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.
Hospital for Special Surgery
New York, New York, United States
Number of Participants With SARS-CoV-2 IgG Antibodies
Prevalence of SARS-CoV-2 IgG antibodies by serology testing in participants at the time of study enrollment or 3 months later
Time frame: Serology Test #1 (Study Enrollment) and Test #2 (3 months apart)
Differences in Sex Between IgG Antibody-positive vs. Negative Participants
Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as sex.
Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
Number of Asymptomatic Participants With Positive Antibody Serology
Number of asymptomatic participants with positive antibody serology at either the study enrollment timepoint or 3 month timepoint
Time frame: Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)
Percentage of Antibody-positive Participants Who Subsequently Develop COVID-19
Percentage of antibody-positive participants who subsequently develop COVID-19 at either the study enrollment timepoint or the 3 months time point
Time frame: Serology Test #1 (Study Enrollment) and Serology Test #2 (3 months apart)
Differences in Race Between IgG Antibody-positive vs. Negative Participants
Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as race.
Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
Differences in Average Number of Adults in Household Between IgG Antibody-positive vs. Negative Participants
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included demographics such as number of adult household members.
Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020
Differences in Comorbidities Between IgG Antibody-positive vs. Negative Participants
Secondary outcomes included differences in the survey responses between IgG antibody-positive and -negative participants. These included comorbidities.
Time frame: Survey completed before or on day of serology testing asking about information from January 1, 2020 to May 5, 2020